LambdaVision reserves Starlab lab space to scale protein‑based artificial‑retina manufacturing
LambdaVision has reserved lab capacity on the planned Starlab commercial space station to advance and scale manufacturing of its protein‑based artificial retina, following microgravity experiments conducted on the ISS. The reservation signals the company’s push to move R&D and production to post‑ISS LEO facilities.